Valérie Paradis

researcher

Valérie Paradis is …
instance of (P31):
humanQ5

External links are
P269IdRef ID117672998
P213ISNI0000000356723163
P496ORCID iD0000-0003-3142-3762
P1153Scopus author ID7005731939
P214VIAF ID189689292

P184doctoral advisorPierre BedossaQ42979649
P185doctoral studentCatherine Paugam-BurtzQ51083916
Nathalie GuedjQ58391145
Nicolas PotéQ58391736
P69educated atParis Descartes UniversityQ1155944
P108employerBeaujon HospitalQ2690409
P735given nameValérieQ18066725
ValérieQ18066725
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

doctoral advisor (P184)
Q51083916Catherine Paugam-Burtz
Q58391145Nathalie Guedj
Q58391736Nicolas Poté

author (P50)
Q57782528A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas
Q57782562A bulky single mass of the liver that revealed a primary hepatic leiomyosarcoma
Q91737631A giant bleeding liver mucinous cystic neoplasm
Q45360205A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
Q28179840A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia
Q96111245ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice
Q39574511Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis
Q57782605Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer
Q56925249Abnormal Plasma Microparticles Impair Vasoconstrictor Responses in Patients With Cirrhosis
Q53196323Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
Q57782582Acute pulmonary embolism
Q38318297Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice
Q51892502Algorithm for immediate cytologic diagnosis of hepatic tumors.
Q34001610Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation
Q43037388An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection
Q43467387Analysis of incidence and pattern of acute rejection episodes after simultaneous pancreas and kidney transplantation
Q53217212Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome.
Q57782614Antioxidant enzymatic activities and renal warm ischemia: correlation with the duration of ischemia
Q35105721Approaches for treatment of liver fibrosis in chronic hepatitis C
Q42199539Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.
Q42277660Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors.
Q44661944Assessment of hepatic steatosis by expert pathologists: the end of a gold standard
Q53521945Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.
Q53567989Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms.
Q57782632Bcl-2 and Bax expression on rat ischemic kidney
Q45958504Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
Q37807575Benign Liver Tumors: An update
Q57782445Benign and malignant hepatocellular lesions in patients with vascular liver disease
Q57782490Benign liver lesions
Q37969722Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group
Q37554449Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma
Q55054786Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Q57782620CD44 IS AN INDEPENDENT PROGNOSTIC FACTOR IN CONVENTIONAL RENAL CELL CARCINOMAS
Q43644252CD44 is an independent prognostic factor in conventional renal cell carcinomas
Q57782622Caverno-pudendal nervous communicating branches in the penile hilum
Q73150709Caverno-pudendal nervous communicating branches in the penile hilum
Q57782494Cellular and molecular techniques
Q35071429Changes in autophagic response in patients with chronic hepatitis C virus infection
Q57782508Changing trends in malignant transformation of hepatocellular adenoma
Q57782625Chester-Erdheim disease: A neoplastic disorder
Q46755865Cholangiocarcinoma: epidemiology and global management
Q57782523Cholangiocarcinome périphérique : corrélations radiopathologiques
Q50864501Clonal analysis of macronodules in cirrhosis.
Q38470673Clonal analysis of renal sporadic angiomyolipomas
Q57782496Colon Tumor Growth and Antivascular Treatment in Mice: Complementary Assessment with MR Elastography and Diffusion-weighted MR Imaging
Q90208486Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma
Q57782544Comment classer une tumeur hépatocytaire bénigne en 2008 ?
Q44911533Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas
Q46157058Comparison of four embolic materials for portal vein embolization: experimental study in pigs
Q51927013Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
Q42272013Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration
Q57782449Complete spontaneous liver graft disappearance after auxiliary liver transplantation
Q57782452Congenital hepatic fibrosis with multiple HNF1α hepatocellular adenomas
Q46317294Congenital portosystemic shunts associated with liver tumours.
Q57782399Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy
Q57782407Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation
Q46360745Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome
Q57782499Cystic hepatobiliary neoplasia
Q34015966Definition and natural history of metabolic steatosis: histology and cellular aspects
Q38985806Detection of liver micrometastases from colorectal origin by perfusion CT in a rat model
Q54441244Development of Collateral Pathways in Tumor Obstruction of Confluence of the Hepatic Veins: Neither Fortuitous nor Innocuous.
Q38773241Diabetes mellitus in patients with cirrhosis: clinical implications and management
Q38245338Diagnosis and management of solid benign liver lesions.
Q38018227Diffusion-weighted MR imaging for the regional characterization of liver tumors.
Q39186073Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference.
Q39995898Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy
Q28581948Dystroglycan expression in hepatic stellate cells: role in liver fibrosis
Q39007454EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
Q45125034Effect of isoproterenol on the cardiac troponin I degradation and release during early TNFalpha-induced ventricular dysfunction in isolated rabbit heart
Q50588057Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients.
Q57184374Endothelial cell-derived microparticles loaded with iron oxide nanoparticles: feasibility of MR imaging monitoring in mice
Q38968181Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.
Q43868971Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma
Q43039600Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study
Q57782565Expression of Epidermal Growth Factor Receptor and Proliferative Activity of Cyst Epithelium in Human Renal Cystic Diseases
Q57782638Expression of aldehydic lipid peroxidation products in rat kidneys during warm ischemia
Q40926848Expression of connective tissue growth factor in experimental rat and human liver fibrosis
Q57782599Expression of cyclooxygenase 2 and prostaglandin E synthase after renal ischemia-reperfusion
Q39277652Extended liver resection for polycystic liver disease can challenge liver transplantation.
Q44688577Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis
Q37523542Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content
Q57782423Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics
Q53321179Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer.
Q36733943Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.
Q39003817Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation
Q57782566Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC
Q33250475Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion.
Q40578851Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors
Q57782572Glycomics: A new taste of cirrhosis marker
Q53342426Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
Q38992720Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease.
Q30488507Hepatic fat fraction and visceral adipose tissue fatty acid composition in mice: Quantification with 7.0T MRI.
Q35645088Hepatic proliferation and angiogenesis markers are increased after portal deprivation in rats: a study of molecular, histological and radiological changes.
Q38720943Hepatocellular Adenomas: WHO Classification and Immunohistochemical Workup
Q45269686Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification
Q36716630Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
Q36758898Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison
Q37769343Hepatocellular carcinoma--what's new?
Q51665999Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.
Q53217245Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.
Q57779831Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors
Q43521896High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.
Q43755024High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis
Q38093561High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging
Q57782512High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver
Q57782429Histology/pathology
Q51353878Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
Q57782474Histopathology of Hepatocellular Carcinoma
Q35010290Hypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas
Q57782627IN SITU DETECTION OF LIPID PEROXIDATION BY-PRODUCTS AS MARKERS OF RENAL ISCHEMIA INJURIES IN RAT KIDNEYS
Q33211462Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases
Q57782574Image of the Month
Q33933462Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis
Q34647317Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas
Q44042540Impact of different combined preservation modalities on warm ischemic kidneys: effect on oxidative stress, hydrostatic perfusion characteristics and tissue damage
Q47851362In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys
Q35126024In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms
Q57782557In the new area of noninvasive markers of hepatocellular carcinoma
Q42510427In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats
Q53478097In vivo anisotropic mechanical properties of dystrophic skeletal muscles measured by anisotropic MR elastographic imaging: the mdx mouse model of muscular dystrophy.
Q44332232In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C.
Q46702703Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease
Q56925226Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis
Q43039572Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation
Q43047910Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis
Q42989933Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
Q41722162Interactions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia
Q57153664Intracystic concentrations of tumour markers for the diagnosis of cystic liver lesions
Q57782559Intraductal papillary mucinous tumors of both biliary and pancreatic ducts
Q57782617Is renal preservation with pulsatile perfusion a model for reperfusion?
Q57782576Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C
Q99707843Liver adenomatosis and NAFLD developed in the context of hereditary fructose intolerance
Q36591012Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings
Q35170449Liver extracellular matrix in health and disease
Q37767323Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT.
Q37398932Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression
Q51808978Liver repopulation trial using bone marrow cells in a retrorsine-induced chronic hepatocellular injury model.
Q38161773Liver resection in patients with hepatic hereditary hemorrhagic telangiectasia
Q57137596Liver steatosis assessed by preoperative MRI: An independent risk factor for severe complications after major hepatic resection
Q34584336Liver transplantation for hepatocellular carcinoma: role of biopsy.
Q53394857Liver tumours in patients with Fanconi anaemia: a report of three cases.
Q39493807Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells.
Q53201713Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin.
Q57782416MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors
Q57782481MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours
Q57145707Massive biliary necrosis as a complication of a hereditary hemorrhagic telangiectasia
Q57782593Measurement of telomere length on tissue sections using quantitative fluorescencein situ hybridization (Q-FISH)
Q36212867Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features
Q39113102Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation
Q39451319Molecular classification of hepatocellular adenoma in clinical practice
Q42990096Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.
Q57782568Multiple mixed adenoma-focal nodular hyperplasia of the liver associated with spontaneous intrahepatic porto-systemic shunt: a new type of vascular malformation associated with the multiple focal nodular hyperplasia syndrome?
Q53208279Neither preoperative computed tomography nor intra-operative examination can predict metastatic lymph node in the hepatic pedicle in patients with colorectal liver metastasis.
Q51287154Neurotensin regulation induces overexpression and activation of EGFR in HCC and restores response to erlotinib and sorafenib.
Q57782435Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN)
Q53076833Obliterative portal venopathy: portal hypertension is not always present at diagnosis.
Q35183888Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease
Q36713620Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update
Q57782479Pathologie hépatique Cirrhose et carcinome hépatocellulaire : indications et rôles de la biopsie hépatique
Q44570406Pathology of cholangiocarcinoma
Q57782515Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet
Q57782569Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Before Liver Transplantation: A Prospective Study with Histopathologic Comparison
Q57782438Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
Q33539003Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study
Q57782600Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis
Q42339215Pre-therapy liver transcriptome landscape in Indian and French patients with severe alcoholic hepatitis and steroid responsiveness.
Q39987989Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab
Q57782463Preoperative tumour biopsy does not affect the oncologic course of patients with transplantable HCC
Q53191508Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.
Q57782578Primary Hepatic Malignant Neoplasms: Radiologic-Pathologic Correlations
Q35198372Progression from cirrhosis to cancer is associated with early ubiquitin post-translational modifications: identification of new biomarkers of cirrhosis at risk of malignancy
Q54135674Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.
Q57782608Prospective Evaluation of Ki–67 Labeling in Predicting the Recurrence and Progression of Superficial Bladder Transitional Cell Carcinoma
Q34072811Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas
Q37993500Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection
Q48068063Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease
Q53375430Quantitative RT-PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis.
Q35597990Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease.
Q57782526Quoi de neuf dans la prise en charge du carcinome hépatocellulaire sur cirrhose ?
Q40998790Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients
Q57782611Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas
Q113871113Reply to: Correspondence regarding “Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies”
Q38751392Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation.
Q42985747Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation.
Q42045352SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules
Q36773151SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions
Q57782629SUCCESSFUL TREATMENT OF ENCRUSTED PYELITIS IN A RENAL TRANSPLANT WITH LOCAL ACIDIFICATION AND SURGICAL ILEOCALICEAL ANASTOMOSIS
Q39618705Selective portal vein ligation and embolization induce different tumoral responses in the rat liver
Q42148070Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden
Q33246213Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin
Q57782538Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery
Q40238516Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
Q33629823Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue
Q35102345Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
Q35597379Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation
Q38734213Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis
Q73007062Successful treatment of encrusted pyelitis in a renal transplant with local acidification and surgical ileocaliceal anastomosis
Q57782602Surgical injuries occurring during kidney procurement performed by a renal transplantation team
Q44501598Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome.
Q53548617TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma.
Q36863160Telangiectatic adenoma: an entity associated with increased body mass index and inflammation.
Q35159416Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases
Q47635380Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.
Q57782645The course of hepatitis C virus infection after liver transplantation
Q43041384The course of hepatitis C virus infection after liver transplantation
Q46713524The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.
Q92679884The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma
Q44560747The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management.
Q47439670The role of replicative senescence in chronic allograft nephropathy.
Q43205518The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study
Q57782547Thrombose portale tumorale et métastase hépatique de cancer colorectal
Q43124491Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib
Q46688979Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.
Q35134122Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry
Q57782506Tumors of the liver
Q46157319Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure
Q30868571Use of laser capture microdissection for clonal analysis
Q40460115Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
Q57782604Value of lipid peroxidation by-products detected during the renal procurement on renal graft function
Q36296298Variant differentiation patterns in primary liver carcinoma
Q51308854Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.
Q30440141Viscoelastic parameters for quantifying liver fibrosis: three-dimensional multifrequency MR elastography study on thin liver rat slices.
Q46122797Well-differentiated hepatocellular neoplasm of uncertain malignant potential
Q57782618What is the value of procurement biopsy lipid peroxidation lesions in the assessment of kidney graft function?
Q41114489When Should We Propose Liver Transplant After Resection of Hepatocellular Carcinoma? A Comparison of Salvage and De Principe Strategies
Q53401358[Prognosis factors of cholangiocarcinoma: contribution of recent molecular biology tools].
Q57782612hTERT expression in sporadic renal cell carcinomas
Q53328591p63 gene expression study and early bladder carcinogenesis.

Q42979649Pierre Bedossadoctoral studentP185